Twist Bioscience Corporation
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-77.7M | $-208.7M | $-204.6M | $-217.9M | $-152.1M | $-139.9M | $-107.7M | $-71.2M |
| Depreciation & Amortization | $24.9M | $31.4M | $29.3M | $16.5M | $9.8M | $6.7M | $6.1M | $5.7M |
| Depreciation | $23.8M | $27.3M | $24.1M | — | — | — | — | — |
| Amortization | $1.1M | $4.1M | $5.3M | $4.9M | $500.0K | $200.0K | — | — |
| Stock-Based Compensation | $64.5M | $50.9M | $30.3M | $79.7M | $37.0M | $17.1M | $11.2M | $3.0M |
| Net Cash from Operating Activities | $-47.6M | $-64.1M | $-142.5M | $-124.4M | $-112.2M | $-142.3M | $-87.9M | $-66.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $28.0M | $5.1M | $27.8M | $101.9M | $27.1M | $9.9M | $14.8M | $3.7M |
| Business Acquisitions | — | $0 | $0 | $8.2M | $483.0K | $0 | — | — |
| Net Cash from Investing Activities | $-24.8M | $-3.1M | $50.6M | $-232.9M | $156.2M | $-114.7M | $-104.8M | $27.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $28.5M | $6.9M | $911.0K | $270.5M | $329.2M | $303.7M | $158.6M | $88.8M |
| Net Change in Cash | $-43.7M | $-60.1M | $-91.0M | $-87.1M | $373.1M | $46.8M | $-34.1M | $50.0M |
| Free Cash Flow | $-75.6M | $-69.2M | $-170.3M | $-226.2M | $-139.3M | $-152.1M | $-102.7M | $-69.9M |